β-eudesmol suppresses allergic reactions via inhibiting mast cell degranulation

Clinical and Experimental Pharmacology and Physiology

Volumn 44, Issue 2, 2017, Pages 257-265

  Han, Na Ra ^a   Moon, Phil Dong ^a   Ryu, Ka Jung ^a   Jang, Jae Bum ^b   Kim, Hyung Min ^a   Jeong, Hyun Ja ^b  

^a Kyung Hee University   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

anaphylaxis; degranulation; ear swelling; histamine; mast cells; eudesmol

Indexed keywords

BETA EUDESMOL; CALCIMYCIN; CALCIUM; COMPOUND 48-80; DEXAMETHASONE; HISTAMINE; HISTIDINE DECARBOXYLASE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; KETOTIFEN; PHORBOL 12 ACETATE 13 MYRISTATE; TRYPTASE; VASCULOTROPIN; ANTIALLERGIC AGENT; BETA-EUDESMOL; CYTOKINE; SESQUITERPENE;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; EAR EDEMA; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MAST CELL DEGRANULATION; MORTALITY; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PERITONEUM MAST CELL; PROTEIN EXPRESSION; RAT; SYSTEMIC ANAPHYLAXIS; ANAPHYLAXIS; ANIMAL; BLOOD; CELL LINE; DEGRANULATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; MAST CELL; PATHOLOGY;

ANAPHYLAXIS; ANIMALS; ANTI-ALLERGIC AGENTS; CELL DEGRANULATION; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; MICE; PASSIVE CUTANEOUS ANAPHYLAXIS; RATS; SESQUITERPENES, EUDESMANE;

EID: 85010383520     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12698     Document Type: Article

References (61)

1. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454:445–454.
2. Amin K. The role of mast cells in allergic inflammation. Respir Med. 2012;106:9–14.
3. Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. Chapter 12. Allergy and Hypersensitivity. In: Immunobiology: The Immune System in Health and Disease, 5th edn. New York, NY: Garland Science; 2001. https://www.ncbi.nlm.nih.gov/books/NBK27112/ Accessed December 14, 2016.
4. Tanaka S, Takasu Y, Mikura S, Satoh N, Ichikawa A. Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J Exp Med. 2002;196:229–235.
5. Urb M, Sheppard DC. The role of mast cells in the defence against pathogens. PLoS Pathog. 2012;8:e1002619.
6. He S, Gaça MD, Walls AF. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharmacol Exp Ther. 1998;286:289–297.
7. Ma HT, Beaven MA. Regulators of Ca(2+) signaling in mast cells: potential targets for treatment of mast cell-related diseases? Adv Exp Med Biol. 2011;716:62–90.
8. Benard A, Desreumeaux P, Huglo D, Hoorelbeke A, Tonnel AB, Wallaert B. Increased intestinal permeability in bronchial asthma. J Allergy Clin Immunol. 1996;97:1173–1178.
9. Powell N, Huntley B, Beech T, Knight W, Knight H, Corrigan CJ. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J. 2007;83:182–186.
10. Caffarelli C, Cavagni G, Deriu FM, Zanotti P, Atherton DJ. Gastrointestinal symptoms in atopic eczema. Arch Dis Child. 1998;78:230–234.
11. Caffarelli C, Deriu FM, Terzi V, Perrone F, De Angelis G, Atherton DJ. Gastrointestinal symptoms in patients with asthma. Arch Dis Child. 2000;82:131–135.
12. Han NR, Kim HM, Jeong HJ. Pyeongwee-San extract (KMP6): a new anti-allergic effect. J Pharm Pharmacol. 2012;64:308–316.
13. Han NR, Moon PD, Kim HM, Jeong HJ. Effect of Pyeongwee-San (KMP6) on 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. Life Sci. 2012;90:147–153.
14. Na-Bangchang K, Karbwang J. Traditional herbal medicine for the control of tropical diseases. Trop Med Health. 2014;42:3–13.
15. Chen LG, Jan YS, Tsai PW, et al. Anti-inflammatory and antinociceptive constituents of atractylodes japonicaa koidzumi. J Agric Food Chem. 2016;64:2254–2262.
16. Seo MJ, Kim SJ, Kang TH, et al. The regulatory mechanism of β-eudesmol is through the suppression of caspase-1 activation in mast cell-mediated inflammatory response. Immunopharmacol Immunotoxicol. 2011;33:178–185.
17. Plengsuriyakarn T, Karbwang J, Na-Bangchang K. Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model. Clin Exp Pharmacol Physiol. 2015;42:293–304.
18. Herranz RM, Herran RMC. Ocular Surface: Anatomy and Physiology, Disorders and Therapeutic Care. Boca Raton, FL: CRC Press; 2013.
19. Kitamura Y, Das AK, Murata Y, et al. Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats. Allergol Int. 2006;55:279–286.
20. Chatterjea D, Wetzel A, Mack M, et al. Mast cell degranulation mediates compound 48/80-induced hyperalgesia in mice. Biochem Biophys Res Commun. 2012;425:237–243.
21. Yu Y, Jia TZ, Cai Q, et al. Comparison of the anti-ulcer activity between the crude and bran-processed Atractylodes lancea in the rat model of gastric ulcer induced by acetic acid. J Ethnopharmacol. 2015;160:211–218.
22. Nogami M, Moriura T, Kubo M, Tani T. Studies on the origin, processing and quality of crude drugs. II. Pharmacological evaluation of the Chinese crude drug “zhu” in experimental stomach ulcer. (2). Inhibitory effect of extract of Atractylodes lancea on gastric secretion. Chem Pharm Bull (Tokyo). 1986;34:3854–3860.
23. Koonrungsesomboon N, Na-Bangchang K, Karbwang J. Therapeutic potential and pharmacological activities of Atractylodes lancea (Thunb.) DC. Asian Pac J Trop Med. 2014;7:421–428.
24. Jayapal M, Tay HK, Reghunathan R, et al. Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genom. 2006;7:210.
25. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18:693–704.
26. Proud D, Bailey GS, Naclerio RM, et al. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992;89:1098–1110.
27. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol. 1990;86:599–605.
28. Ohtsu H, Tanaka S, Terui T, et al. Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett. 2001;502:53–56.
29. Moya-Garcia AA, Medina MA, Sánchez-Jiménez F. Mammalian histidine decarboxylase: from structure to function. BioEssays. 2005;27:57–63.
30. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987;316:1622–1626.
31. Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J. 2002;19:879–885.
32. Kempuraj D, Madhappan B, Christodoulou S, et al. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol. 2005;145:934–944.
33. Nishida K, Yamasaki S, Ito Y, et al. Fc{epsilon}RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol. 2005;170:115–126.
34. Chahdi A, Fraundorfer PF, Beaven MA. Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTP-binding proteins. J Pharmacol Exp Ther. 2000;292:122–130.
35. Park JB, Lee CS, Jang JH, et al. Phospholipase signalling networks in cancer. Nat Rev Cancer. 2012;12:782–792.
36. Ohara K, Fukuda T, Okada H, et al. Identification of significant amino acids in multiple transmembrane domains of human transient receptor potential ankyrin 1 (TRPA1) for activation by eudesmol, an oxygenized sesquiterpene in hop essential oil. J Biol Chem. 2015;290:3161–3171.
37. Kimura I, Tsuneki H, Kondoh T, Kimura M. Enhancing effect by nicotinic acetylcholine receptor channel blockers, including beta-eudesmol, on succinylcholine-induced inhibition of twitch tension and intracellular Ca++ in mouse diaphragm muscle. J Pharmacol Exp Ther. 1991;256:24–28.
38. Ochi H, De Jesus NH, Hsieh FH, Austen KF, Boyce JA. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci USA. 2000;97:10509–10513.
39. Boyton RJ, Altmann DM. Asthma: new developments in cytokine regulation. Clin Exp Immunol. 2004;136:13–14.
40. Jancar S, Sirois MG, Carrier J, Braquet P, Sirois P. PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis. Inflammation. 1991;15:347–354.
41. Mican JA, Arora N, Burd PR, Metcalfe DD. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol. 1992;90:815–824.
42. Toru H, Pawankar R, Ra C, Yata J, Nakahata T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol. 1998;102:491–502.
43. Lorentz A, Schwengberg S, Sellge G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol. 2000;164:43–48.
44. Song Z, Casolaro V, Chen R, Georas SN, Monos D, Ono SJ. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol. 1996;156:424–429.
45. Lee AJ, Ro M, Park J, Jang JH, Kim JH. The synthesis of VEGF in allergen-stimulated mast cells is through a leukotriene B4 receptor-2-dependent signaling pathway. J Immunol. 2016;196:53.2.
46. Woolley DE, Tetlow LC. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2000;2:65–74.
47. Bocşan CI, Bujor AI, Miron N, Vesa ŞC, Deleanu D, Buzoianu AD. In vivo anti-inflammatory effect of H1 antihistamines in allergic rhinitis: a randomized clinical trial. Balkan Med J. 2015;32:352–358.
48. Kim NH, Kang IC, Kim HM, Jeong HJ. Evaluation of Moon-tang on allergic reactions. Immunopharmacol Immunotoxicol. 2011;33:384–390.
49. Han NR, Moon PD, Nam SY, et al. Inhibitory effects of atractylone on mast cell-mediated allergic reactions. Chem Biol Interact. 2016;258:59–68.
50. Kim HY, Nam SY, Hwang SY, Kim HM, Jeong HJ. Atractylone, an active constituent of KMP6, attenuates allergic inflammation on allergic rhinitis in vitro and in vivo models. Mol Immunol. 2016;78:121–132.
51. Oh HA, Kim HM, Jeong HJ. Alleviation of allergic rhinitis symptoms with Pyeongwee-San extract (KMP6). Immunopharmacol Immunotoxicol. 2012;34:135–142.
52. Li Y, Li T, Miao C, Li J, Xiao W, Ma E. β-Eudesmol induces JNK-dependent apoptosis through the mitochondrial pathway in HL60 cells. Phytother Res. 2013;27:338–343.
53. Ben Sghaier M, Mousslim M, Pagano A, Ammari Y, Luis J, Kovacic H. β-eudesmol, a sesquiterpene from Teucrium ramosissimum, inhibits superoxide production, proliferation, adhesion and migration of human tumor cell. Environ Toxicol Pharmacol 2016;46:227–233.
54. Tsuneki H, Ma EL, Kobayashi S, et al. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur J Pharmacol. 2005;512:105–115.
55. Moon PD, Na JJ, Jeong HJ, et al. Inhibitory effect of Gamibojungikgitang extract on mast cell-mediated allergic reaction in murine model. J Pharm Pharm Sci. 2005;8:94–101.
56. Jungfer B, Jansen T, Przybilla B, Plewig G. Solid persistent facial edema of acne: successful treatment with isotretinoin and ketotifen. Dermatology. 1993;187:34–37.
57. Shoeb A, Chowta M, Pallempati G, Rai A, Singh A. Evaluation of antidepressant activity of vanillin in mice. Indian J Pharmacol. 2013;5:141–144.
58. Kim HM, Lee EH, Hong SH, et al. Effect of Syzygium aromaticum extract on immediate hypersensitivity in rats. J Ethnopharmacol. 1998;60:125–131.
59. Jeong HJ, Lee SA, Moon PD, et al. Alginic acid has anti-anaphylactic effects and inhibits inflammatory cytokine expression via suppression of nuclear factor-kappaB activation. Clin Exp Allergy. 2006;36:785–794.
60. Penissi AB, Vera ME, Mariani ML, et al. Novel anti-ulcer alpha, beta-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation. Eur J Pharmacol. 2009;612:122–130.
61. Kim J, Kang D, Kang M, et al. A comparison of the effects of dexamethasone-pharmacopuncture and dexamethasone-oral administration based on traditional Korean medicine theory on anaphylactic reaction in mice. TANG. 2013;3:e24.